JAZZ PHA reported $915.89M in Operating Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Aerie Pharmaceuticals AERI:US USD 62.8M 11.35M
ALKERMES ALKS:US USD 313M 2.32M
Amarin AMRN:US USD 95.02M 62.25M
Cara Therapeutics CARA:US USD 34.66M 7.18M
Coherus Biosciences CHRS:US USD 125.87M 21.71M
Eli Lilly And LLY:US USD 5.27B 12.8M
Emergent Biosolutions EBS:US USD 282M 32.7M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Halozyme Therapeutics HALO:US USD 128.4M 10.09M
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Hikma Pharmaceutical HIK:LN USD 964M 118M
Horizon Pharma HZNP:US USD 764.75M 23.1M
IONIS PHARMACEUT IONS:US USD 218.92M 384K
Lannett LCI:US USD 88.11M 64.04M
Mckesson MCK:US USD 69.03B 2.92B
Merk MRK:US USD 10.97B 1.31B
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Pfizer PFE:US USD 13.23B 2.41B
Revance Therapeutics RVNC:US USD 106.5M 20.29M
Supernus Pharmaceuticals SUPN:US USD 178.88M 20.17M
Teva Pharmaceutical Industries TEVA:US USD 3.18B 1.56B
Xeris Pharmaceuticals Inc XERS:US USD 48.5M 4.28M
Zoetis ZTS:US USD 1.34B 47M